Antagonists of gonadotropin releasing hormone
AssigneeMerck & Co., Inc.
InventorsMark Goulet, Lin Chu, Thomas F. Walsh, Michael H. Fisher, Narindar N. Girotra, Matthew J. Wyvratt, Peter Lin, Wallace T. Ashton
Life of this patent
Estimating the term…
Abstract
There are disclosed compounds of formula (I) ##STR1## and pharmaceutically acceptable salts thereof which are useful as antagonists of GnRH and as such may be useful for the treatment of a variety of sex-hormone related and other conditions in both men and women.
Claims27
A compound of the formula ##STR294## wherein A is C.sub.1 -C.sub.6 alkyl optionally substituted with one or more halogen, C.sub.3 -C.sub.7 cycloalkyl, substituted C.sub.3 -C.sub.7 cycloalkyl, C.sub.3 -C.sub.6 alkenyl, substituted C.sub.3 -C.sub.6 alkenyl, C.sub.3 -C.sub.6 alkynyl, substituted C.sub.3 -C.sub.6 alkynyl, C.sub.1 -C.sub.6 alkoxy, or C.sub.0 -C.sub.5 alkyl-S(O).sub.n -C.sub.0 -C.sub.5 alkyl, C.sub.0 -C.sub.5 alkyl-O-C.sub.0 -C.sub.5 alkyl, C.sub.0 -C.sub.5 alkyl-NR.sub.18 -C.sub.0 -C.sub.5 alkyl where R.sub.18 and the C.sub.0 -C.sub.5 alkyl do not form a ring, or a single bond;
- R.sub.0 is hydrogen, C.sub.1 -C.sub.6 alkyl, substituted C.sub.1 -C.sub.6 alkyl, wherein the substituents are as defined below;
- aryl, substituted aryl, aralkyl or substituted aralkyl, wherein the substituents are as defined for R.sub.3, R.sub.4 and R.sub.5 ;
- R.sub.1 is ##STR295## R.sub.2 is hydrogen, C.sub.1 -C.sub.6 alkyl, substituted C.sub.1 -C.sub.6 alkyl, aralkyl, substituted aralkyl, aryl, substituted aryl, alkyl --OR.sub.11, C.sub.1 -C.sub.6 (NR.sub.11 R.sub.12), C.sub.1 -C.sub.6 (CONR.sub.11 R.sub.12) or C(NR.sub.11 R.sub.12)NH;
- R.sub.2 and A taken together form a ring of 5-7 atoms;
- R.sub.3, R.sub.4 and R.sub.5 are independently hydrogen, C.sub.1 -C.sub.6 alkyl, substituted C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.6 alkenyl, substituted C.sub.2 -C.sub.6 alkenyl, CN, nitro, or halogen;
- R.sub.6 is hydrogen, C.sub.1 -C.sub.6 alkyl, substituted C.sub.1 -C.sub.6 alkyl, aryl, substituted aryl, C.sub.1 -C.sub.3 perfluoroalkyl, CN, NO.sub.2, halogen, R.sub.11 O(CH.sub.2).sub.p --, NR.sub.12 C(O)R.sub.11, NR.sub.12 C(O)NR.sub.11 R.sub.12 or SO.sub.n R.sub.11 ;
- R.sub.7 is hydrogen, C.sub.1 -C.sub.6 alkyl, or substituted C.sub.1 -C.sub.6 alkyl, unless X is hydrogen or halogen, then R.sub.7 is absent;
- R.sub.8 is hydrogen, C(O)OR.sub.9, C(O)NR.sub.11 R.sub.12, C(O)R.sub.11, NR.sub.12 C(O)R.sub.11, NR.sub.12 C(O)NR.sub.11 R.sub.12, NR.sub.12 S(O).sub.2 R.sub.11, NR.sub.12 S(O).sub.2 NR.sub.11 R.sub.12, OC(O)R.sub.11, OC(O)NR.sub.11 R.sub.12, OR.sub.11, SO.sub.n R.sub.11, S(O).sub.n NR.sub.11 R.sub.12, C.sub.1 -C.sub.6 alkyl or substituted C.sub.1 -C.sub.6 alkyl, unless X is hydrogen or halogen, then R.sub.8 is absent;
- or
- R.sub.7 and R.sub.8 taken together form a carbocyclic ring of 3-7 atoms;
- R.sub.9 and R.sub.9a are independently hydrogen, C.sub.1 -C.sub.6 alkyl, substituted C.sub.1 -C.sub.6 alkyl;
- aryl or substituted aryl, aralkyl or substituted aralkyl when m.notident.0;
- or
- R.sub.9a and A taken together form a ring containing 3-7 carbon atoms when m.notident.0;
- or
- R.sub.10 and R.sub.10a are independently hydrogen, C.sub.1 -C.sub.6 alkyl, substituted C.sub.1 -C.sub.6 alkyl, aryl, substituted aryl, aralkyl or substituted aralkyl;
- R.sub.11 and R.sub.12 are independently hydrogen, C.sub.1 -C.sub.6 alkyl, substituted C.sub.1 -C.sub.6 alkyl, aryl, substituted aryl, aralkyl, substituted aralkyl, a carbocyclic ring of 3-7 atoms or a substituted carbocyclic ring containing 3-7 atoms;
- R.sub.11 and R.sub.12 taken together can form an optionally substituted ring of 3-7 atoms;
- R.sub.13 is hydrogen, OH, NR.sub.20 R.sub.21, NR.sub.11 SO.sub.2 (C.sub.1 -C.sub.6 alkyl), NR.sub.11 SO.sub.2 (substituted C.sub.1 -C.sub.6 alkyl), NR.sub.11 SO.sub.2 (aryl), NR.sub.11 SO.sub.2 (substituted aryl), NR.sub.11 SO.sub.2 (C.sub.1 -C.sub.3 perfluoroalkyl);
- SO.sub.2 NR.sub.11 (C.sub.1 -C.sub.6 alkyl), SO.sub.2 NR.sub.11 (substituted C.sub.1 -C.sub.6 alkyl), SO.sub.2 NR.sub.11 (aryl), SO.sub.2 NR.sub.11 (substituted aryl), SO.sub.2 NR.sub.11 (C.sub.1 -C.sub.3 perfluoroalkyl);
- SO.sub.2 NR.sub.11 (C(O)C.sub.1 -C.sub.6 alkyl);
- SO.sub.2 NR.sub.11 (C(O)-substituted C.sub.1 -C.sub.6 alkyl);
- SO.sub.2 NR.sub.11 (C(O)-aryl);
- SO.sub.2 NR.sub.11 (C(O)-substituted aryl);
- S(O).sub.n (C.sub.1 -C.sub.6 alkyl);
- S(O).sub.n (substituted C.sub.1 -C.sub.6 alkyl), S(O).sub.n (aryl), S(O).sub.n (substituted aryl), C.sub.1 -C.sub.3 perfluoroalkyl, C.sub.1 -C.sub.3 perfluoroalkoxy, C.sub.1 -C.sub.6 alkoxy, substituted C.sub.1 -C.sub.6 alkoxy, COOH, halogen, NO.sub.2 or CN;
- R.sub.14 and R.sub.15 are independently hydrogen, C.sub.1 -C.sub.6 alkyl, substituted C.sub.1 -C.sub.6 alkyl, C.sub.2 -C.sub.6 alkenyl, substituted C.sub.2 -C.sub.6 alkenyl, CN, nitro, C.sub.1 -C.sub.3 perfluoroalkyl, C.sub.1 -C.sub.3 perfluoroalkoxy, aryl, substituted aryl, aralkyl, substituted aralkyl, R.sub.11 O(CH.sub.2).sub.p --, R.sub.11 C(O)O(CH.sub.2).sub.p --, R.sub.11 OC(O)(CH.sub.2).sub.p --, --(CH.sub.2).sub.p S(O).sub.n R.sub.17, --(CH.sub.2).sub.p C(O)NR.sub.11 R.sub.12 or halogen;
- wherein R.sub.17 is hydrogen, C.sub.1 -C.sub.6 alkyl, C.sub.1 -C.sub.3 perfluoroalkyl, aryl or substituted aryl;
- or
- R.sub.13 and R.sub.14 taken together form an oxo group;
- R.sub.18 is hydrogen;
- R.sub.19 is either the definition of R.sub.13 or R.sub.14 ;
- R.sub.20 and R.sub.21 are independently hydrogen, C.sub.1 -C.sub.6 alkyl or substituted C.sub.1 -C.sub.6 alkyl;
- X is hydrogen, halogen, N, O, S(O).sub.n, C(O), (CR.sub.11 R.sub.12).sub.p ;
- when X is hydrogen or halogen, R.sub.7 and R.sub.8 are absent;
- when X is O, S(O)n, C(O), or CR.sub.11 R.sub.12 only one of R.sub.7 or R.sub.8 is present;
- Z is O, S, or NR.sub.11 ;
- with the proviso that if only one heterocyclic atom is present it must be N;
- m is 0-3;
- n is 0-2;
- p is 0-;
- and the alkyl, alkenyl and alkynyl substituents are selected from C.sub.1 -C.sub.6 alkyl, C.sub.3 -C.sub.7 cycloalkyl, aryl, substituted aryl, aralkyl, substituted aralkyl, hydroxy, oxo, cyano, C.sub.1 -C.sub.6 alkoxy, fluoro, COOH, C(O)O(C.sub.1 -C.sub.6)alkyl, aryl C.sub.1 -C.sub.3 alkoxy, substituted aryl C.sub.1 -C.sub.3 alkoxy, and the aryl substituents are as defined for R.sub.3, R.sub.4 and R.sub.5 ;
- or a pharmaceutically acceptable addition salt and/or hydrate thereof, or where applicable, a geometric or optical isomer or racemic mixture thereof.
Dependencies are inferred from the claim text.